Cedars-Sinai’s center provides personalized, multidisciplinary care for RA and related conditions, improving patient outcomes and quality of life. Dr. Jon Giles' research explores autoimmune disease ...

NEW YORK — Patients with rheumatoid arthritis (RA) carry a high risk for cardiovascular events, but mounting clinical evidence suggests they're being undertreated to manage that risk. Rheumatologists ...

METHOTREXATE delay for 1 month after 13 valent pneumococcal conjugate vaccination did not worsen rheumatoid arthritis disease control, structural progression, or treatment escalation over 1 year, ...

Please provide your email address to receive an email when new articles are posted on . The next new treatment for rheumatoid arthritis could come from the unlikeliest of sources. Researchers based at ...

Editor’s note: This is an automatically generated transcript. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription. First of all, I think that we struggle with ...

In a real-world, prospective study, upadacitinib demonstrated great potential for the treatment of rheumatoid arthritis (RA) regardless of a patient’s baseline C-reactive protein (CRP) levels.

This is an excellent question because conclusions from evidence-based medicine studies of this issue are sparse in comparison with guidelines from expert panels. The question itself may be turned on ...

Functional MRI studies have established that subjective feelings of pain and fatigue have objective correlates in terms of neuronal activity patterns. This study sought to determine whether neural ...

What’s the Goal of Treat to Target? Usually, your goal for RA treatment is remission. This is when you have no clinical signs of active inflammation. RA remission is based on your blood tests, ...